Clinical trials
Withdrawn Phase 1 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Virginia | 3 |
| Pfizer | 2 |
| Vanderbilt University Medical Center | 2 |
| Baystate Medical Center | 1 |
| Bristol-Myers Squibb | 1 |
| Columbia University | 1 |
| Duke University | 1 |
| Jenny Tong, MD, MPH | 1 |
| Novo Nordisk A/S | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 19 |
| Insulin Resistance | 4 |
| Polycystic Ovary Syndrome | 3 |
| Diabetes Mellitus | 2 |
| Hyperinsulinism | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Overweight | 2 |
| Arthritis, Juvenile | 1 |
| Arthritis, Rheumatoid | 1 |
| Burns | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.